Clinical Trial Update: Donepezil, Residual Excessive Daytime Sleepiness, Obstructive Sleep Apnea [Phase 4]

View source ↗

Summary

Phase 4 clinical trial investigating donepezil for residual excessive daytime sleepiness in obstructive sleep apnea; the current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obstructive Sleep Apnea

Drugs mentioned

• Donepezil (donepezil)

Snippet

Sponsor: Associação Fundo de Incentivo à Pesquisa | Conditions: OSA, Sleepiness | Phase 4 | Status: UNKNOWN